Xylotox hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

80 API Suppliers, 13 USDMF, 11 CEP/COS, 3 JDMF, 7 EU WC, 15 KDMF, 28 NDC API, 38 Listed Suppliers

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

699 FDF Dossiers, 233 FDA Orange Book, 334 Europe, 68 Canada, 17 South Africa, 47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%, INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;SPINAL - 5%, JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 6 Rochem International Inc, 12 SPI Pharma, 1 PMC Isochem, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Capital Farma, 15 Kirsch Pharma, 11 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 22 Actylis, 3 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 43 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 5 CD Formulation, 1 Clariant, 17 Corel Pharma Chem, 3 Doshion Polyscience, 2 Esteem Industries, 5 Finar, 13 Gangwal Chemicals, 3 Gloria Interchem, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 9 Lubrizol Life Science Health, 9 Microlex e.U, 3 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 25 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 Symrise, 3 The Dow Chemical Company, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Topical, 67 Solubilizers, 50 Thickeners and Stabilizers, 46 Parenteral, 46 Coating Systems & Additives, 39 Emulsifying Agents, 37 Fillers, Diluents & Binders, 31 Controlled & Modified Release, 27 Film Formers & Plasticizers, 25 Surfactant & Foaming Agents, 18 API Stability Enhancers, 18 Granulation, 18 Taste Masking, 17 Direct Compression, 13 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 7 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 67 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 25 Regulatory FDF Prices

MARKET PLACE

58 APIs, 15 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

Xls

Filters

Xylotox Hydrochloride

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

PEGS Boston Summit

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

PEGS Boston Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Xylotox hydrochloride? Find Coloring Agents used in Xylotox hydrochloride to address drug delivery challenges on PharmaCompass.

Xylotox hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

80 API Suppliers

13 USDMF

11 CEP/COS

3 JDMF

7 EU WC

15 KDMF

28 NDC API

38 Listed Suppliers

DEVELOPMENTS

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

699 FDF Dossiers

233 FDA Orange Book

334 Europe

68 Canada

17 South Africa

47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%

INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.005MG/ML;0.5%

INJECTABLE;INJECTION - 0.005MG/ML;1%

INJECTABLE;INJECTION - 0.005MG/ML;1.5%

INJECTABLE;INJECTION - 0.005MG/ML;2%

INJECTABLE;INJECTION - 0.01MG/ML;1%

INJECTABLE;INJECTION - 0.01MG/ML;2%

INJECTABLE;INJECTION - 0.02MG/ML;2%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 1.5%

INJECTABLE;INJECTION - 2%

INJECTABLE;INJECTION - 1%

INJECTABLE;INJECTION - 2%

INJECTABLE;INJECTION - 1%

INJECTABLE;SPINAL - 5%

JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Evonik

6 Rochem International Inc

12 SPI Pharma

1 PMC Isochem

1 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Capital Farma

15 Kirsch Pharma

11 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

22 Actylis

3 Aeon Procare

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

43 BASF

1 Bioplus Life Sciences

1 BioSpectra

5 CD Formulation

1 Clariant

17 Corel Pharma Chem

3 Doshion Polyscience

2 Esteem Industries

5 Finar

13 Gangwal Chemicals

3 Gloria Interchem

3 Ideal Cures

2 Ingredion Pharma Solutions

10 Kerry

INJECTABLE;INJECTION - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 20% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

JELLY;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons